Philippa Gardner

Edison Investment Research

Recent Quotes

"THLD's TH-302 for glioblastoma could be eligible for accelerated development."

— Philippa Gardner, Edison Investment Research (11/18/14)
more >



Due to permission requirements, not all quotes are shown.